December 23, 2014

Duri Cosmetics is launching for spring/summer 2015 a new city-inspired line of nail polish.

December 22, 2014

Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.

December 22, 2014

Salon Grafix has announced the relaunch of the cult-favorite Professional hair spray.

December 22, 2014

Sandoz has announced the U.S. market introduction of estradiol transdermal system, an authorized generic version of Vivelle-Dot, which is marketed by Novartis Pharmaceuticals.

December 19, 2014

India's skincare brand, Clean & Clear, has announced the launch of its new Pimple Clearing Face Wash.

December 19, 2014

M.D. Science Lab, manufacturers of Swiss Navy Premium Lubricants, on Thursday unveiled all-new packaging for their brand for mass-market storefronts.

December 19, 2014
Rinovum Women’s Health, a privately held, U.S.-based women’s health company, announced Friday that it has secured $3 million in a series C financing from its existing investor base.
December 19, 2014

Teva Pharmaceutical announced that the Food and Drug Administration approved QNasl (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis in children ages 4 years to 11 years.

December 18, 2014

Dr. Reddy’s Laboratories announced Tuesday that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of the antiviral Valcyte (Valganciclovir) tablets, in the U.S. market.

December 17, 2014

Skin care company Adovia has debuted its new Natural Sulfur Soap enriched with minerals and sulfur from the Dead Sea.

December 17, 2014

To date, the Food and Drug Administration's Center for Drug Evaluation and Research has approved 35 novel new drugs in 2014, compared to 27 in 2013. 

December 17, 2014

The Food and Drug Administration on Wednesday approved Xtoro (finafloxacin otic suspension), a new drug that's used to treat acute otitis externa, commonly known as swimmer's ear. 

December 17, 2014

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.

December 17, 2014

PL Developments on Wednesday announced that it has added menopause relief supplement, EstroG-100, to its private-label portfolio.

December 16, 2014

Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. 

 

December 16, 2014

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

December 16, 2014

Living Essentials on Monday introduced its new Strawberry Watermelon-flavored Extra Strength 5-hour Energy shot, which also has six regular strength flavors, as well as decaf. 

December 16, 2014

Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use. 

 

December 15, 2014

Simply Beverages, the makers of Simply Orange and Simply Lemonade beverages, is adding a line of juices to its portfolio. 

December 12, 2014

Premium skin care company Arithmetic has officially launched its Acne Control Complex.  Optimized to help adults achieve clear, healthy skin, each product includes premium ingredients and natural moisturizers.

December 12, 2014

Sanofi Pasteur announced that the FDA approved the supplemental biologics license application for Fluzone Intradermal Quadrivalent vaccine.

December 12, 2014

Entrepreneur Ceata E. Lash experienced migraines when wearing elastic bands on her voluminous, naturally coily hair. Frustrated, she set out on a mission to create a functional tool to both secure big hair and allow it to maintain fullness without cinching, pulling or causing the user pain. Enter the PuffCuff Hair Clamp.

December 11, 2014

With the youngest of the baby boomers having turned 50 this year, adult incontinence is proving to be a high-traffic, high-frequency category with a decent amount of margin, at least in the drug channel. According to Competitive Promotion Report, the drug channel enjoys a 35% margin in this category on average.

December 11, 2014

Australian Dream is one of those hot external analgesic products that has been growing by greater than 20% across all channels. Drug Store News had an opportunity to dig a little deeper regarding the Nature s Health Connection s Australian Dream product with David Biernbaum of David Biernbaum and Assoc., who represents the product.